The Global Inflammatory Bowel Disease Treatment Market Report by TBRC covers the market drivers and restraints, market size, major players & impact of COVID-19
LONDON, GREATER LONDON, UK, August 11, 2022 /EINPresswire.com/ — According to ‘Inflammatory Bowel Disease Treatment Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the inflammatory bowel disease treatment market size is expected to grow from $19.52 billion in 2021 to $20.48 billion in 2022 at a compound annual growth rate (CAGR) of 4.93%. The global inflammatory bowel disease market size is expected to grow to $24.84 billion in 2026 at a compound annual growth rate (CAGR) of 4.94%. The rising prevalence of Crohn’s disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market growth.
Want to learn more on the inflammatory bowel disease treatment market growth? Request for a Sample now:
The inflammatory bowel disease treatment market consists of sales of inflammatory bowel disease therapeutics and drugs by entities (organizations, partnerships, and sole proprietors) that are used to provide medical treatment for inflammatory bowel diseases. Inflammatory bowel disease refers to two medical conditions, Crohn’s disease and ulcerative colitis, characterized by chronic inflammation of the gastrointestinal (GI) tract. Treatment for inflammatory bowel disease aims to minimize the inflammation, maintain remission, and prevent complications.
Global Inflammatory Bowel Disease Treatment Market Trends
Technological advancement is a key trend gaining popularity in the inflammatory bowel disease treatment market. The key players in the inflammatory bowel disease treatment market are focusing on using technology such as artificial intelligence (AI) for the drug discovery process as well as offering advanced but new inflammatory bowel disease treatments. To attain their technological innovations, key players and technology companies are partnering to leverage each other’s competencies and technology to develop new treatments and strengthen their key position in the market.
Global Inflammatory Bowel Disease Treatment Market Segments
The global inflammatory bowel disease treatment market is segmented:
By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Others
By Type: Crohn’s Disease, Ulcerative Colitis
By Route of Administration: Oral, Injectable
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Geography: The global inflammatory bowel disease treatment market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.
Read more on the global inflammatory bowel disease treatment market report at:
Inflammatory Bowel Disease Treatment Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides inflammatory bowel disease treatment global market overviews, analyzes and inflammatory bowel disease treatment industry forecast market size and growth, inflammatory bowel disease treatment global market share, inflammatory bowel disease treatment global market segmentation and geographies, inflammatory bowel disease treatment global market players, inflammatory bowel disease treatment global market leading competitor revenues, profiles and market shares. The inflammatory bowel disease treatment market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.
TBRC’s Inflammatory Bowel Disease Treatment Global Market Report 2022 includes information on the following:
Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies
Key Market Players: AbbVie Inc, Biogen, Johnson & Johnson, Amgen Inc, UCB SA, Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co, Pfizer Inc, Abbott Laboratories, Janssen Biotech Inc, Eli Lilly, Allergan plc, Alkem Laboratories Limited, and Bausch Health Companies Inc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
And so much more.
Looking for something else? Here is a list of similar reports by The Business Research Company:
Gastrointestinal Drugs Global Market Report 2022
Gastrointestinal Devices Global Market Report 2022
Digestive Enzymes Global Market Report 2022
About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Check out our:
Market Research Products, Services, Solutions For Your Business – TBRC